AWMDMG
ERNA icon

Austin W. Marxe & David M. Greenhouse’s Eterna Therapeutics ERNA Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.65M Hold
11
– – 0.36% 75
2014
Q2 		$4.22M Buy
+11
New +$4.83M 0.53% 62

Other funds holding ERNA

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's ERNA Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its Eterna Therapeutics (ERNA) position steady in Q3 2014 at 11 shares worth $2.65M. The position accounts for 0.36% of the portfolio, ranked #75.

Austin W. Marxe & David M. Greenhouse first reported a position in ERNA in Q2 2014 and has held it in 2 quarters since. The position peaked at $4.22M in Q2 2014. 7 funds tracked by Wall St. Rank hold ERNA as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse held 11 shares of Eterna Therapeutics worth $2.65M as of Q3 2014.
  • Austin W. Marxe & David M. Greenhouse left its Eterna Therapeutics share count unchanged in Q3 2014.
  • Eterna Therapeutics made up 0.36% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #75 holding.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Eterna Therapeutics in Q2 2014 and has held it in 2 quarters since.
  • Austin W. Marxe & David M. Greenhouse's Eterna Therapeutics position peaked at $4.22M in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.